EDITH GRANNUM: Open Payments
NPI 1821060237 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,701 in 102 payments from 17 companies in 2025. Trend: 2023 $1,530 · 2024 $1,592 · 2025 $2,701
Food & beverage: $2,701
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $505 |
| Novo Nordisk Inc | 12 | $480 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $358 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $210 |
| ABBVIE INC. | 13 | $196 |
| PFIZER INC. | 5 | $148 |
| Verona Pharma, Inc. | 2 | $143 |
| Amgen Inc. | 1 | $125 |
| Lilly USA, LLC | 5 | $118 |
| Phathom Pharmaceuticals, Inc. | 7 | $98 |
Products named: Ozempic, Kerendia, FARXIGA, JARDIANCE, AIRSUPRA, Ohtuvayre, Otezla, MOUNJARO.
Industry payments across NY — which companies pay providers there.
